gip glp 1 agonist tirzepatide Dual GLP-1/GIP | | Obesity & T2DM Mx | Harrison's Update(22nd Ed.) New Weight-Loss Drugs Are Poised
Description
Daniel Drucker [Biomarker April 2023] 3
Zhang, J., et al., Novel Dual and Triple Agonists Targeting GLP-1, GIP, Glucagon, and GDF15 for Type 2 Diabetes and Obesity Management
Impact of glucagon-like peptide-1 receptor agonists on adiponectin concentrations: A meta-analysis of randomized controlled trials
Bagsvaerd, Denmark: Novo Nordisk
Fasting GLP-1 levels were similar after both surgeries [14]
The three glucose-lowering medications are common second-line therapies recommended by the guidelines [8, 9]
